Emmetrope Ophthalmics, a leader in cell-based therapies for severe eye diseases, today announced the...
read moreTopcon Healthcare has announced an investment in RetiSpec, marking the beginning of a collaboration ...
read moreAurion Biotech has officially completed the dosing of all participants in its phase 1/2 clinical tri...
read moreInflammasome Therapeutics has officially dosed the first patient in a pioneering clinical trial aime...
read moreIn a significant leadership shift, Topcon Healthcare announced Ali Tafreshi as its new President and...
read moreNaegis Pharmaceuticals Inc., a life sciences company specializing in inflammation and ophthalmology,...
read moreL.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the Unive...
read moreRevOpsis Therapeutics has announced the successful closure of its first seed funding round, securing...
read moreVerana Health has introduced its Qdata Thyroid Eye Disease (TED) module, a new addition to its suite...
read moreLEP Biomedical announced pre-seed funding of €100,000 ($107,000) over two 6-month periods, which the...
read more